1. Beutler, B. A., Milsark, I. W. & Cerami, A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 135, 3972–3977 (1985).
2. Blick, M., Sherwin, S. A., Rosenblum, M. & Gutterman, J. Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer research 47, 2986–2989 (1987).
3. Chapman, P. B. et al. Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. Journal of clinical oncolog: official journal of the American Society of Clinical Oncology 5, 1942–1951 (1987).
4. Zahn, G. & Greischel, A. Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta. Arzneimittel-Forschung 39, 1180–1182 (1989).
5. Aggarwal, B. B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3, 745–756, doi: 10.1038/nri1184 (2003).